Adrenomedullin 2 plays diverse physiological roles such as regulating cardiovascular functions and blood pressure. It was reported that adrenomedullin 2 can activate protein kinase C in murine ventricular myocytes to augment cardiomyocyte contractile function. Using a protein kinase Cα knockout mouse model, we show here that adrenomedullin 2 activates extracellular-signal-regulated kinase in a protein kinase Cα-independent mechanism in endothelial cells.
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Adrenomedullin 2 activates extracellular-signal-regulated kinase in F1000Research endothelial cells via a protein kinase C α-independent pathway [ , The Jakson Laboratory, Cat # B6;129-Prkcatm1Jmk/J) and maintained as previously described 6 . Briefly, the arteries of both wild-type and knockout mice were harvested, finely minced with scissors, and digested with 25 ml collagenase (2 mg/ml) at 37°C for 45 min under gentle agitation. The crude preparation was triturated, passing it 12 times through a cannula needle, and was then filtered on a 70-μM sterile cell strainer. The filtered preparation was spun at 400 × g, and the pellet was resuspended in 2 ml of 0.1% BSA. Magnetic beads (Invitrogen) coated with anti-mouse CD31 (BD Biosciences) were added to the cell suspension and incubated with rotation at room temperature for 15 min. The bead-bound cells were recovered with a magnetic separator and washed with DMEM containing 20% FBS. Cells were suspended in 10 ml of complete DMEM and seeded on cell culture plates (Catalog # 353003, Corning Inc., Corning, NY). Subconfluent cells were serum-starved for 16h followed by incubation with 10 ng/ml ADM2 peptide (Pheonix Pharmaceuticals, Burlingame, CA) for the indicated time length: 0, 5, and 30min . Cells were lysed in RIPA buffer (Catalog # R0278, Sigma-Aldrich, St Louis, MI), supplemented with protease inhibitor cocktail (Catalog # 11 873 580 001, Roche Diagnostics, Mannheim, Germany) and phosphatase inhibitor cocktails (Catalog # P0044 and P5726, Sigma-Aldrich, St Louis, MI) as instructed by manufactures. Total cell lysates were subjected to immunoblotting analysis as described previously As shown in Figure 1 , ADM2 increased phosphorylation of ERK in endothelial cells. However, there was no difference in ERK phosphorylation levels in wt versus PKCα null endothelial cells (Figure 1) . Our results indicate that ADM2 activates ERK in endothelial cells via a PKCα -independent pathway. ). Cells were serum-starved overnight followed by stimulation with ADM2 synthetic peptide (10ng/ml) for indicated time and cell lysates were analyzed by immunoblotting for ERK activation.
Data availability
F1000Research: Dataset 1. Gel images for 'Adrenomedullin 2 activates extracellular-signal-regulated kinase in endothelial cells via a protein kinase C α-independent pathway' by Guo X., et al., 10.5256/f1000research.2420.d110689 7 Author contributions XG cultured and treated cells and performed Western analyses, and prepared the manuscript; RJ isolated endothelial cells from mice, CC and MS directed the study.
Competing interests
There is no disclosure of competing interests.
Grant information
This work is supported by OHSE fund (Department of Surgery, Yale School of Medicine) funding to XG.
1.

2.
3.
protein kinase C α-independent pathway" presents an elegant mutational analysis of cellular activation by the enigmatic adrenomedullin 2. Endothelial cells harvested from PKC-α knock out mice still demonstrate ERK phosphorylation, suggesting that the current paradigm of ADM2 intracellular activation (ADM2 signalling occurring through a PKC receptor pathway) is not completely understood. While this work is limited in scope, it does set a foundation for needed work in this field. There are some technical and context specific elements which would significantly strengthen this research note.
Major points:
Which specific ADM2 peptide was used? It would be helpful to mention this in the methods; ADM2-47 is believed to be the more potent agonist compared to the -40 peptide. Perhaps it would also be appropriate to test both ADM2 peptides (both -47 and -40) for comparison.
The abstract and introduction sets the context for this work by describing ADM2 signalling in cardiomyocytes, but this research note presents data for arterial endothelial cells. The addition of the same phospho-Westerns for the same PKC-α knock out mouse cardiomyocytes would address this criticism.
The results section is clearly presented, but a brief discussion and conclusion to put these results in a physiologic context would again enhance the impact of this research note. Specifically, this reviewer could cite a review by where it is stated that the receptors that mediate Hong 
